Comment on "The effectiveness and safety of topical beta-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies"

Br J Clin Pharmacol. 2022 Jan;88(1):358. doi: 10.1111/bcp.14941. Epub 2021 Aug 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists* / adverse effects
  • Hemangioma* / drug therapy
  • Humans
  • Research

Substances

  • Adrenergic beta-Antagonists